allodynia and tirzepatide New Weight Loss Drugs Are Wildly Effective, But They Aren't Cost Effective | by F. Perry Wilson, MD Tirzepatide Dual Agonist (GLP-1/GIP) |

Physiol Mol Biol Plants 32 , 961979 (2026)

Government Shutdown: The federal government shutdown has affected agencies like the FDA, potentially delaying new drug approvals

It behaves like one

boosting acetylcholine provides substrate for learning Caution: Acetylcholinesterase inhibitors were noted to reduce fosgonimeton efficacy in clinical trials (ACT-AD finding), suggesting potential interference Unknown interaction: Dihexa + cholinergics have not been formally studied Modafinil Some stacking discussions mention modafinil (a eugeroic/wakefulness-promoting agent): Rationale: Addresses alertness while Dihexa targets learning and neuroprotection Interaction risk: Both affect dopamine and executive function